This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2005 Jun;2(6):296-7.

doi: 10.1038/ncponc0200.

EGFR point mutation confers resistance to gefitinib in a patient with non-small-cell lung cancer

Giuseppe Giaccone¹

Affiliations

PMID: 16264986
DOI: 10.1038/ncponc0200

Comment

EGFR point mutation confers resistance to gefitinib in a patient with non-small-cell lung cancer

Giuseppe Giaccone. Nat Clin Pract Oncol. 2005 Jun.

. 2005 Jun;2(6):296-7.

doi: 10.1038/ncponc0200.

Author

Giuseppe Giaccone¹

Affiliation

¹ Department of Medical Oncology, Free University Medical Center, Amsterdam, The Netherlands. g.giaccone@vumc.nl

PMID: 16264986
DOI: 10.1038/ncponc0200

No abstract available

PubMed Disclaimer

Comment on

EGFR mutation and resistance of non-small-cell lung cancer to gefitinib.
Kobayashi S, Boggon TJ, Dayaram T, Jänne PA, Kocher O, Meyerson M, Johnson BE, Eck MJ, Tenen DG, Halmos B. Kobayashi S, et al. N Engl J Med. 2005 Feb 24;352(8):786-92. doi: 10.1056/NEJMoa044238. N Engl J Med. 2005. PMID: 15728811

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
Research Materials
- NCI CPTC Antibody Characterization Program
Miscellaneous
- NCI CPTAC Assay Portal